Trial NCT02743975

View at ClinicalTrials.gov 
Org. Study IDs: NL50488.042.15

Last trial update was posted on 2020-01-28

MeSH Interventions

Bevacizumab

MeSH Conditions

Adenocarcinoma

Other Conditions

Pancreatic Adenocarcinoma Pancreatic Cancer

Stopping Reasons

Insufficient tumor-to-background ratios in the first three dose groups

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID